Font Size * * *
share it

TTA Led 12 Startups to Attend the MedTech Conference 2019


The annual MedTech Conference has become one of the iconic exhibitions in the Eastern United States over the past few years, bringing together diverse exhibitors, including influential industry decision-makers, executives, venture capitals, and the media. The MedTech Conference 2019 saw more than 3,300 of the world’s top biomedical executives from 39 countries. More than 2,200 one-on-one business meetings were scheduled through the MedTech Connect platform, which was a 34% percent increase over 2018.


The Ministry of Science and Technology (MOST) coordinated Taiwan’s technology and startup resources from the Industrial Value Creation Program for Academia and BioMed Commercialization Center to send 12 startups specialized in digital healthcare and biotech to exhibit at the MedTech Conference 2019.

Exhibitors at the venue


Led by Tu Chun-Yi, Deputy Director-General of Department of Academia-Industry Collaboration and Science Park Affairs of MOST, the 12 startup teams attended the conference under the name of Taiwan Tech Arena (TTA) and showcased Taiwanese innovation and technology to potential clients and investors over the three-day Conference. The Conference also featured Exhibit Hall, Innovator Showcase, Exce Talks, Solutions Showcase, and CEO Unplugged, where attendees learned the latest regulations on MedTech industry or experiences of business management shared by industry leaders and influencers.

The MedTech Conference Exhibit Hall

After the MedTech Conference, TTA led four startups (Professor Wu Bing-Fei of NCTU, Professor Yao Ming of NTU, Heroic-Faith Medical Science, and Riche Biotech Inc.) to visit Massachusetts General Hospital (MGH). During the trip, Deputy Director-General Tu introduced how MOST dedicates to seeking resources overseas and supporting Taiwanese startups. The four startup teams also pitched their products to three representatives of MGH.

TTA visiting the Massachusetts General Hospital


TTA also arranged a Taiwan Demo Day at CIC Boston, during which 9 startup teams exhibited Taiwan’s innovation in biotech. The Demo Day also invited five speakers from local enterprises, including Leading Business Ventures, MPM Capital, Alira Health, Flare Capital, and Medtronic, to share their experiences and views in the trend, venture capital, and startup. During their speeches, venture capitalists emphasized that market size, the potential for entering the international market, and profitability are the primary considerations. They suggested that when pitching to investors, startups teams must clearly show the potential market value, target clients, and milestones of their businesses to encourage investment. 


Led by TTA, the 12 startup teams attending the Conference not only had a chance to pitch in front of investors in biomedical sciences and healthcare from the U.S. but also showed the efforts of the Taiwanese government in supporting startups. Through this Conference, TTA reaffirmed that Taiwan’s startups are at a competitive edge, especially when compared with Europe and the U.S. Taiwan is renowned for its capability in industries such as healthcare, information and communication technology, and smart manufacturing, therefore, the government should anchor domestic tech startup ecosystem to attract more international exhibitions, accelerators, and venture capitals to visit and exhibit in Taiwan. If Taiwanese startup teams could continue to explore and showcase at the global platform, they will undoubtedly break new ground for Taiwan’s biomedical technology.

Taiwan’s startup teams pitching to the venture capitals from the Eastern United States